This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from inorganic growth, growth in commissions revenue and financial flexibility.
Should You Retain Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Continued mobile subscriber growth, organic growth across distribution channels and effective capital deployment continue to drive Assurant (AIZ).
Reasons Why MGIC Investment (MTG) Stock is an Attractive Pick
by Zacks Equity Research
MGIC Investment (MTG) is poised to gain from a favorable loss reserve development, higher consolidated investment portfolio and investment yields, and prudent capital deployment.
Can James River Group (JRVR) Climb 26% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 26.2% in James River Group (JRVR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
James River Group (JRVR) Q2 Earnings Surpass Estimates
by Zacks Equity Research
James River Group (JRVR) delivered earnings and revenue surprises of 6.12% and 5.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
RLI Corporation (RLI) Up 10% in a Year: More Room to Run?
by Tanuka De
RLI Corporation (RLI) is poised to grow on a compelling portfolio, a focus on specialty insurance lines, an impressive record of underwriting profits and effective capital deployment.
Reasons Why Investors Should Retain EverQuote (EVER) Stock Now
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, the solid performance of automotive insurance providers and financial flexibility.
Here's Why Should You Stay Invested in Assurant (AIZ) Stock
by Zacks Equity Research
Strength in Global Lifestyle business, growth in fee-based capital-light businesses and solid capital management poise Assurant (AIZ) well for growth.
Here's Why Investing in MGIC Investment (MTG) is Prudent Now
by Zacks Equity Research
MGIC Investment (MTG) is poised to gain from a favorable loss reserve development, higher consolidated investment portfolio and investment yields and effective capital deployment.
American Equity (AEL) Up 21% in a Year: More Room to Run?
by Zacks Equity Research
A compelling product portfolio, increasing popularity of index products in the market, focus on expansion into new verticals, solid balance sheet and effective capital deployment continue to drive American Equity Investment Life Holding (AEL).
Why You Should Hold on to Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) benefits from its international presence, favorable underwriting results, higher earnings from joint venture investments and effective capital deployment
Arthur J. Gallagher (AJG) Up 17% in a Year: More Room to Run?
by Zacks Equity Research
Strong performing Brokerage and Risk Management segments, strategic buyouts to capitalize on growing markets opportunities, effective capital deployment and upbeat guidance continue to drive Arthur J. Gallagher (AJG).
Here's Why Hold Strategy is Appropriate for Radian Group (RDN)
by Zacks Equity Research
Radian Group (RDN) is poised to grow due to well-performing real estate services and valuation products, favorable growth estimates and effective capital deployment.
Assurant (AIZ) Rallies 15% YTD: Can It Retain the Momentum?
by Zacks Equity Research
The well-performing Global Lifestyle business, growth in fee-based capital-light businesses and solid capital management continue to drive Assurant (AIZ).
Should You Retain Brighthouse (BHF) Stock in Your Portfolio?
by Zacks Equity Research
Brighthouse (BHF) is well poised for growth on the back of higher underwriting margin, strong annuity sales, lower expenses and prudent capital deployment.
Reasons to Hold Trupanion (TRUP) Stock in Your Portfolio Now
by Zacks Equity Research
Trupanion (TRUP) is poised to grow on a change in the attitude of pet owners who are focusing on pets' health and well-being in an underpenetrated pet insurance market, product launches and extended operating boundaries.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, solid performance of automotive insurance providers and sufficient liquidity.
Why You Should Hold on to Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) benefits from favorable underwriting, lower expenses, financial flexibility and cost savings initiatives.
Wall Street Analysts Think James River Group (JRVR) Could Surge 77%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 76.7% in James River Group (JRVR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
James River Group (JRVR) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
James River Group (JRVR) delivered earnings and revenue surprises of 54.17% and 1.79%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 17.15% and 1.23%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
TowneBank (TOWN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
TowneBank (TOWN) delivered earnings and revenue surprises of 5% and 0.73%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
James River Group (JRVR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
James River Group (JRVR) delivered earnings and revenue surprises of -493.48% and 5.46%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Lags Q4 Earnings Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of -40% and 0.45%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
James River Group (JRVR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
James River Group (JRVR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.